Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Breast Journal
|
April 11, 2012
Breast cancer detection method among 20- to 49-year-old patients at a community based cancer center: 1990-2008
Judith Malmgren, Mary Atwood, Henry Kaplan
Breast Cancer Research and Treatment
|
January 1, 2013
Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study
Henry Kaplan, Judith Malmgren, Anneclaire J De Roos
Transfusion
|
August 13, 2015
Drug-induced immune hemolytic anemia associated with anti-carboplatin and the first example of anti-paclitaxel
Regina M Leger, Shweta Jain, Theresa A Nester, et al.
The Journal of Urology
|
January 22, 2008
Metastatic adenocarcinoma after augmentation gastrocystoplasty
Vijaya M Vemulakonda, Thomas S Lendvay, Margarett Shnorhavorian, et al.
JNCI Cancer Spectrum
|
November 25, 2024
Social determinants of health and variability in treatment for patients with early-stage non-small cell lung cancer
Molly Scannell Bryan, Xiaohan Hu, Monika A Izano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma
Thomas E Witzig, Peter H Wiernik, Timothy Moore, et al.
Journal of Hematology & Oncology
|
June 13, 2014
A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors
Sven de Vos, Andres Forero-Torres, Stephen M Ansell, et al.
Plos One
|
November 17, 2021
Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
Yonghou Jiang, Fergal Duffy, Jennifer Hadlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
Angela DeMichele, Douglas Yee, Donald A Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2023
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery
Kathy S Albain, Christina Yau, Emanuel F Petricoin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Breast Journal
|
April 11, 2012
Breast cancer detection method among 20- to 49-year-old patients at a community based cancer center: 1990-2008
Judith Malmgren, Mary Atwood, Henry Kaplan
Breast Cancer Research and Treatment
|
January 1, 2013
Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study
Henry Kaplan, Judith Malmgren, Anneclaire J De Roos
Transfusion
|
August 13, 2015
Drug-induced immune hemolytic anemia associated with anti-carboplatin and the first example of anti-paclitaxel
Regina M Leger, Shweta Jain, Theresa A Nester, et al.
The Journal of Urology
|
January 22, 2008
Metastatic adenocarcinoma after augmentation gastrocystoplasty
Vijaya M Vemulakonda, Thomas S Lendvay, Margarett Shnorhavorian, et al.
JNCI Cancer Spectrum
|
November 25, 2024
Social determinants of health and variability in treatment for patients with early-stage non-small cell lung cancer
Molly Scannell Bryan, Xiaohan Hu, Monika A Izano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 7, 2009
Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma
Thomas E Witzig, Peter H Wiernik, Timothy Moore, et al.
Journal of Hematology & Oncology
|
June 13, 2014
A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors
Sven de Vos, Andres Forero-Torres, Stephen M Ansell, et al.
Plos One
|
November 17, 2021
Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
Yonghou Jiang, Fergal Duffy, Jennifer Hadlock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2015
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer
Angela DeMichele, Douglas Yee, Donald A Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 18, 2023
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery
Kathy S Albain, Christina Yau, Emanuel F Petricoin, et al.
Page
of 1